Primary Angioplasty or Thrombolysis: Choosing the Right Reperfusion Strategy

Cardiac echo is important and is now done routinely, alongside cardiac enzymes and ECG, in suspected cases of heart attack at every tertiary care hospital where it is available. In summary, once ischemic heart disease is confirmed, every patient is loaded with aspirin (325 mg) along with clopidogrel (300 mg), prasugrel (60 mg) or ticagrelor (180 mg), a statin (atorvastatin or rosuvastatin, 40 to 80 mg), a beta blocker if blood pressure and heart rate allow, and glyceryl trinitrate for pain relief alongside oxygen. From there, ST-elevation MI patients receive heparin ahead of primary angioplasty, or are thrombolyzed if angioplasty is unavailable; non-ST-elevation MI and unstable angina patients are managed medically with low molecular weight heparin or fondaparinux instead of thrombolysis, and are escalated to coronary angiography and angioplasty or bypass surgery if they are high-risk or not improving.

Myocardial bridging can cause chest pain and can act as a risk factor. The initial approach is medical management with beta blockers, calcium channel blockers or nitrates. If the patient's chest pain continues despite medication, the next step is bypass surgery rather than angioplasty, since angioplasty is not successful in a bridged segment of artery.

Aspirin, clopidogrel, statins and beta blockers are all safe in pregnancy and can be used without hesitation. Low molecular weight heparin is also safe. ACE inhibitors should not be given, and thrombolysis is contraindicated outright in pregnant patients; these patients should instead be referred for primary angioplasty. The mother's life takes priority, though the fetal risk should be explained to the family before proceeding.

There are three glycoprotein 2b3a inhibitors: abciximab, tirofiban and eptifibatide. These were used far more commonly a decade ago, before stents and catheterization labs were as standardized and widely available as they are now. Today their use has decreased and they are reserved for high-risk patients, such as those with a high thrombotic burden or delayed presentation, because of the increased risk of bleeding in the brain, stomach and at the local puncture site.

The prognosis is poor when a patient with ST-elevation MI cannot be thrombolyzed because of a contraindication. Ideally these patients should be sent for primary angioplasty; if that is also unavailable, they should be managed medically in an ICU with aspirin, clopidogrel or ticagrelor, statins, beta blockers, ACE inhibitors, nitrates and heparin or low molecular weight heparin, using whatever resources are available. Outcomes can be described as roughly 50/50: some patients respond well to this treatment, while others deteriorate and need referral to a higher-level facility.

Within 90 to 120 minutes. Beyond that window, thrombolysis becomes the preferred option instead of transferring the patient.

A good clinical history, symptom onset under 12 hours, and an ECG showing ST elevation or a new left bundle branch block, combined with no cath lab being reachable in time.